(Q41763924)

9 October 2017

In vitro activity of ciprofloxacin compared with those of other new fluorinated piperazinyl-substituted quinoline derivatives (English)

1 reference

9 October 2017

Van Caekenberghe DL

1

1 reference

9 October 2017

Pattyn SR

series ordinal

2

1 reference

9 October 2017

language of work or name

English

0 references

publication date

1 April 1984

1 reference

Antimicrobial Agents and Chemotherapy

9 October 2017

1 reference

9 October 2017

25

1 reference

9 October 2017

4

1 reference

9 October 2017

518-521

1 reference

In vitro antibacterial activity of AM-715, a new nalidixic acid analog

9 October 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185569

In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents

6 June 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185569

[A new synthetic antibacterial : 1-ethyl-6-fluoro-7-(4-methyl-1-piperazinyl)-4-oxo-1, 4-dihydroquinolin-3-carboxylic acid (1589 R.B.)]

6 June 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/6732221

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.25.4.518

1 reference

release_azgz3y2nwjgrpmgglflsdbarhu

9 October 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/azgz3y2nwjgrpmgglflsdbarhu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

9 October 2017

PubMed publication ID

6732221

1 reference